LG Chem acquires approval of the first antibody biosimilar ‘Eucept’
LG Chem will aim for the Korean antibody biosimilar market.
LG Chem announced on the 16th that the company acquired approval of ‘Eucept,’ a biosimilar product referencing ‘etanercept,’ an autoimmune disease treatment, from the Ministry of Food and Drug Safety(MFDS).
Eucept, the LG Chem’s first ...
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.